|
健保碼及健保價 |
|
See related Cerezyme inj[雪瑞素 注射劑 ""] information |
|
|
|
製造商 |
Genzyme |
|
代理/經銷商 |
TSPC |
|
成份 |
Imiglucerase |
|
適應症 |
Type 1 Gaucher's disease. |
|
用量 |
Initially, 2.5 u/kg 3 times a week to 60 u/kg once every 2 week by IV infusion over 1-2 hr. Individualized dosage adjustments. |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
注意事項 |
Monitor periodically for IgG antibody formation during the 1st year. Anaphylactoid reactions. Hypersensitivity to alglucerase. Pregnancy & lactation. |
|
不良反應 |
Discomfort, pruritus, burning, swelling or sterile abscess at the site of venipuncture. Hypersensitivity & anaphylactoid reactions. Nausea, abdominal pain, vomiting, diarrhea, rash, fatigue, headache, fever, dizziness, chills, backache & tachycardia.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
Genzyme |
|
Distributor: |
TSPC
|
|
|
|
